BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 23424657)

  • 1. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Luo W; Li S; Peng B; Ye Y; Deng X; Yao K
    PLoS One; 2013; 8(2):e56324. PubMed ID: 23424657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer.
    Li N; Deng W; Ma J; Wei B; Guo K; Shen W; Zhang Y; Luo S
    Med Oncol; 2015 Jan; 32(1):433. PubMed ID: 25491144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
    Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
    Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
    You L; Guo X; Huang Y
    Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
    Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
    J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells.
    Dong D; Meng L; Yu Q; Tan G; Ding M; Tan Y
    Gene Expr; 2012; 15(4):153-62. PubMed ID: 22783724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanog expression is negatively regulated by protein kinase C activities in human cancer cell lines.
    Chu WK; Dai PM; Li HL; Pao CC; Chen JK
    Carcinogenesis; 2013 Jul; 34(7):1497-509. PubMed ID: 23536578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.
    Park E; Park SY; Sun PL; Jin Y; Kim JE; Jheon S; Kim K; Lee CT; Kim H; Chung JH
    Oncotarget; 2016 Jul; 7(27):42502-42512. PubMed ID: 27285762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
    Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
    Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors.
    Liu A; Cheng L; Du J; Peng Y; Allan RW; Wei L; Li J; Cao D
    Am J Surg Pathol; 2010 May; 34(5):697-706. PubMed ID: 20410807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.
    Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotency transcription factors and cancer stem cells: small genes make a big difference.
    Liu A; Yu X; Liu S
    Chin J Cancer; 2013 Sep; 32(9):483-7. PubMed ID: 23419197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
    Santagata S; Ligon KL; Hornick JL
    Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryonic stem cells markers Oct4 and Nanog correlate with perineural invasion in human salivary gland mucoepidermoid carcinoma.
    Destro Rodrigues MF; Sedassari BT; Esteves CM; de Andrade NP; Altemani A; de Sousa SC; Nunes FD
    J Oral Pathol Med; 2017 Feb; 46(2):112-120. PubMed ID: 27131799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.
    Luo W; Fang W; Li S; Yao K
    Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma.
    Luo WR; Yao KT
    Virchows Arch; 2014 Jan; 464(1):35-43. PubMed ID: 24248285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 20. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells.
    Wang Z; Oron E; Nelson B; Razis S; Ivanova N
    Cell Stem Cell; 2012 Apr; 10(4):440-54. PubMed ID: 22482508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.